Literature DB >> 22641750

Intermittent intraperitoneal dose of teicoplanin in peritoneal dialysis-related peritonitis.

V Liakopoulos, K Leivaditis, O Nikitidou, M Divani, G Antoniadi, N Dombros.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22641750      PMCID： PMC3525438          DOI： 10.3747/pdi.2011.00171

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN： 0896-8608            Impact factor:   1.756


× No keyword cloud information.
  5 in total

1.  Peritoneal dialysis-related infections recommendations: 2010 update.

Authors:  Philip Kam-Tao Li; Cheuk Chun Szeto; Beth Piraino; Judith Bernardini; Ana E Figueiredo; Amit Gupta; David W Johnson; Ed J Kuijper; Wai-Choong Lye; William Salzer; Franz Schaefer; Dirk G Struijk
Journal:  Perit Dial Int       Date:  2010 Jul-Aug       Impact factor: 1.756

2.  Intermittent versus continuous intraperitoneal glycopeptide/ceftazidime treatment in children with peritoneal dialysis-associated peritonitis. The Mid-European Pediatric Peritoneal Dialysis Study Group (MEPPS).

Authors:  F Schaefer; G Klaus; D E Müller-Wiefel; O Mehls
Journal:  J Am Soc Nephrol       Date:  1999-01       Impact factor: 10.121

3.  Pharmacokinetic behavior of intraperitoneal teicoplanin during treatment of peritonitis complicating continuous ambulatory peritoneal dialysis.

Authors:  R C Finch; A P Holliday; A Innes; R P Burden; A G Morgan; P N Shaw; I Harding; M C Wale
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

4.  Pharmacokinetics of teicoplanin in patients undergoing continuous ambulatory peritoneal dialysis.

Authors:  Dimitrios Stamatiadis; Maria G Papaioannou; Evangelos J Giamarellos-Bourboulis; Smaragda Marinaki; Helen Giamarellou; Charalambos P Stathakis
Journal:  Perit Dial Int       Date:  2003 Mar-Apr       Impact factor: 1.756

5.  A prospective, randomized trial of two antibiotic regimens in the treatment of peritonitis in CAPD patients: teicoplanin plus tobramycin versus cephalothin plus tobramycin.

Authors:  A Lupo; C Rugiu; P Bernich; A Laudon; C Marcantoni; G Mosconi; M C Cantaluppi; G Maschio
Journal:  J Antimicrob Chemother       Date:  1997-11       Impact factor: 5.790
  5 in total
  2 in total

Review 1.  Peritoneal dialysis-related infections recommendations: 2016 update. What is new?

Authors:  Vassilios Liakopoulos; Olga Nikitidou; Theofanis Kalathas; Stefanos Roumeliotis; Marios Salmas; Theodoros Eleftheriadis
Journal:  Int Urol Nephrol       Date:  2017-06-01       Impact factor: 2.370

Review 2.  ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment.

Authors:  Philip Kam-Tao Li; Cheuk Chun Szeto; Beth Piraino; Javier de Arteaga; Stanley Fan; Ana E Figueiredo; Douglas N Fish; Eric Goffin; Yong-Lim Kim; William Salzer; Dirk G Struijk; Isaac Teitelbaum; David W Johnson
Journal:  Perit Dial Int       Date:  2016-06-09       Impact factor: 1.756
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.